The Cell Cycle Regulatory Proteins p16, CDK4 , and PTEN Are Unsuitable as Biomarkers in Oral Melanocytic Lesions
Journal of Oral Pathology & Medicine · 2025
DOI: 10.1111/jop.13607 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, 2025. Verfasst von Aline Queiroz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oral and Maxillofacial Pathology, School of Dentistry, University of São Paulo, São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase 4, PTEN Phosphohydrolase, Melanoma, Cyclin-Dependent Kinase Inhibitor p16. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Background
Melanocytic neoplasms are rare in the oral cavity and represent a diagnostic challenge due to the overlap between benign and malignant lesions. However, their pathogenesis is not fully elucidated. The aim of this study was to evaluate the expression of the cell cycle‐related proteins p16, CDK4, and PTEN in oral melanocytic nevi and melanomas.
Methods
A total of 42 cases of melanocytic nevi and five cases of melanoma underwent immunohistochemical analysis. Cases were scored as 0, 1 (< 5% of positive cells), 2 (6%–50% of positive cells), and 3 (> 50% of positive cells). Statistical significance was set at p ≤ 0.05.
Results
Two cases of melanocytic nevi were totally negative for p16 and 95.2% of cases scored 1. For CDK4, 47.6% of the cases scored 2 and 52.4% scored 3. For PTEN, 97.6% of the cases scored 3 and only one case showed a score of 2. All melanoma cases were classified with a score of 2 for p16, and for CDK4 and PTEN, all cases exhibited a score of 3. PTEN and CDK4 were higher expressed when compared to p16 both in melanocytic nevi and melanomas ( p < 0.001), and melanocytic nevi showed low expression of p16 when compared to melanomas ( p < 0.0001).
Conclusion
The findings suggest that these cell cycle‐related proteins are not useful biomarkers in melanocytic lesions of the oral mucosa and support the apparent biological distinction between oral and cutaneous lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Oral and Maxillofacial Pathology, School of Dentistry, University of São Paulo, São Paulo, São Paulo, Brazil.
- Programa de Pós-Graduação em Odontologia, School of Dentistry, Ceuma University, São Luís, Maranhão, Brazil.
ORCID-Profile: Aline Queiroz, Thalita Santana, Marília Trierveiler
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Queiroz, A., Santana, T., Paris, A. F. C., & Trierveiler, M. (2025). The Cell Cycle Regulatory Proteins p16, CDK4 , and PTEN Are Unsuitable as Biomarkers in Oral Melanocytic Lesions. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.13607
Vancouver
Queiroz A, Santana T, Paris AFC, Trierveiler M. The Cell Cycle Regulatory Proteins p16, CDK4 , and PTEN Are Unsuitable as Biomarkers in Oral Melanocytic Lesions. Journal of Oral Pathology & Medicine. 2025. doi:10.1111/jop.13607
BibTeX
@article{Queiroz2025,
author = {Queiroz, Aline and Santana, Thalita and Paris, Adriana Fraga Costa and Trierveiler, Marília},
title = {The Cell Cycle Regulatory Proteins p16, CDK4 , and PTEN Are Unsuitable as Biomarkers in Oral Melanocytic Lesions},
journal = {Journal of Oral Pathology & Medicine},
year = {2025},
doi = {10.1111/jop.13607}
}
EUVIMED